← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Old Republic International Corporation (ORI) 10-Year Financial Performance & Capital Metrics

ORI • • Insurance & Managed Care
Financial ServicesDiversified InsuranceMulti-Line InsuranceRegional Multi-Line Insurers
AboutOld Republic International Corporation, through its subsidiaries, engages in the insurance underwriting and related services business primarily in the United States and Canada. The company operates through three segments: General Insurance, Title Insurance, and the Republic Financial Indemnity Group Run-off Business. The General Insurance segment offers automobile extended warranty, aviation, commercial automobile, commercial multi-peril, commercial property, general liability, home warranty, inland marine, travel accident, and workers' compensation insurance products; and financial indemnity products for specialty coverages, including errors and omissions, fidelity, guaranteed asset protection, and surety. This segment provides its insurance products to businesses, government, and other institutions in transportation, commercial construction, healthcare, education, retail and wholesale trade, forest products, energy, general manufacturing, and financial services industries. The Title Insurance segment offers lenders' and owners' title insurance policies to real estate purchasers and investors based upon searches of the public records. This segment also provides escrow closing and construction disbursement services; and real estate information products, national default management services, and various other services pertaining to real estate transfers and loan transactions. The Republic Financial Indemnity Group Run-off Business segment offers private mortgage insurance coverage that protects mortgage lenders and investors from default related losses on residential mortgage loans made primarily to homebuyers. The company was founded in 1923 and is based in Chicago, Illinois.Show more
  • Revenue $8.23B +13.4%
  • Combined Ratio 87.01% -3.0%
  • Net Income $853M +42.4%
  • Return on Equity 14.18% +48.9%
  • Medical Cost Ratio 36.74% +3.4%
  • Operating Margin 12.99% +26.2%
  • Net Margin 10.36% +25.6%
  • ROA 3.14% +35.4%
  • Equity / Assets 20.18% -16.6%
  • Book Value per Share 21.35 -4.9%
  • Tangible BV/Share 21.35 -4.9%
  • Debt/Equity 0.28 +13.9%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Profitable underwriting: 87.0% combined ratio
  • ✓Strong Piotroski F-Score: 7/9
  • ✓Low loss ratio of 36.7%
  • ✓Healthy dividend yield of 2.4%
  • ✓Share count reduced 7.8% through buybacks

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y4.06%
5Y1.99%
3Y-4.13%
TTM7.09%

Profit (Net Income) CAGR

10Y7.61%
5Y-4.19%
3Y-17.78%
TTM-11.09%

EPS CAGR

10Y8.45%
5Y-1.59%
3Y-13.75%
TTM-5.41%

ROCE

10Y Avg6.08%
5Y Avg6.37%
3Y Avg3.82%
Latest3.94%

Peer Comparison

Regional Multi-Line Insurers
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
GSHDGoosehead Insurance, Inc1.8B72.1062.1620.37%8.55%108.93%3.93%3.93
ORIOld Republic International Corporation10.69B43.3213.3713.41%9.53%12.95%11.54%0.28
HIGThe Hartford Financial Services Group, Inc.36.49B130.8212.648.44%12.84%19.28%15.8%0.27
AIZNAssurant, Inc. 5.25% Subordinat1.03B20.171.396.7%6.75%14.74%100%0.41

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Revenue+5.77B5.9B6.26B6.26B7.46B7.17B9.34B8.08B7.26B8.23B
Revenue Growth %0.04%0.02%0.06%-0%0.19%-0.04%0.3%-0.13%-0.1%0.13%
Medical Costs & Claims+5.07B5.15B5.45B5.52B5.82B2.47B2.4B2.43B2.58B3.02B
Medical Cost Ratio %----------
Gross Profit+691.6M754.2M808M737.1M1.64B4.69B6.94B5.66B4.68B5.21B
Gross Margin %----------
Gross Profit Growth %0.06%0.09%0.07%-0.09%1.22%1.87%0.48%-0.19%-0.17%0.11%
Operating Expenses+60M68.4M82.8M299.2M314.3M4B5.02B4.8B3.93B4.14B
OpEx / Revenue %----------
Depreciation & Amortization0000000000
Combined Ratio %----------
Operating Income+631.6M685.8M725.2M437.9M1.32B688.1M1.92B857.1M747.3M1.07B
Operating Margin %----------
Operating Income Growth %0.04%0.09%0.06%-0.4%2.02%-0.48%1.79%-0.55%-0.13%0.43%
EBITDA+673.7M736.2M788.4M480.3M1.36B732.1M1.98B924.1M817.9M1.15B
EBITDA Margin %----------
Interest Expense41.9M50.2M63M42.2M40M43.7M56.2M66.7M70.5M77.3M
Non-Operating Income-42.1M-50.4M-63.2M-42.4M-40.2M-44M-56.4M-67M-70.6M-77.4M
Pretax Income+631.8M686M725.4M438.1M1.32B688.4M1.92B857.4M747.4M1.07B
Pretax Margin %----------
Income Tax+209.6M219M164.8M67.6M265.9M129.7M387.7M170.9M148.7M216.9M
Effective Tax Rate %----------
Net Income+422.1M466.9M560.5M370.5M1.06B558.6M1.53B686.4M598.6M852.7M
Net Margin %----------
Net Income Growth %0.03%0.11%0.2%-0.34%1.85%-0.47%1.75%-0.55%-0.13%0.42%
EPS (Diluted)+1.481.621.921.233.511.875.052.262.103.24
EPS Growth %0.03%0.09%0.19%-0.36%1.85%-0.47%1.7%-0.55%-0.07%0.54%
EPS (Basic)1.631.802.141.263.521.875.082.282.123.30
Diluted Shares Outstanding296.09M296.38M299.39M301.02M301.23M298.9M303.67M303.3M285.47M263.18M

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Assets+17.11B18.59B19.4B19.33B21.08B22.82B24.98B25.16B26.5B27.84B
Asset Growth %0.01%0.09%0.04%-0%0.09%0.08%0.09%0.01%0.05%0.05%
Total Investment Assets+1.99B2.9B3.27B3.38B14.36B15.33B16.58B15.86B15.87B16.08B
Long-Term Investments1.99B2.9B3.27B3.38B14.33B15.3B5.3B3.22B15.83B16.04B
Short-Term Investments00009.28B11.25B11.24B12.61B13.17B2.84B
Total Current Assets+170.3M223.7M292.9M13.64B0018.12B20.22B00
Cash & Equivalents9.37B9.97B10.15B9.68B78.8M118.7M158.1M81M202.8M201.9M
Receivables00001000K1000K1000K1000K1000K1000K
Other Current Assets0000-14.66B-17.32B3.82B5.15B-21.55B-12.44B
Goodwill & Intangibles+255.4M274M297.8M490.3M00349M356.2M00
Goodwill000174M00174.5M178.1M00
Intangible Assets255.4M274M297.8M316.3M00174.5M178.1M00
PP&E (Net)03.15B2.71B-771M004.62B-677.8M00
Other Assets-255.4M-2.9B-3.27B9.58B-14.33B-15.3B-5.3B12.61B-15.83B-16.04B
Total Liabilities13.23B14.12B14.67B14.18B15.08B16.63B18.09B18.99B20.09B22.22B
Total Debt+961.7M1.53B1.45B981.3M973.9M966.4M1.59B1.6B1.59B1.59B
Net Debt-8.4B-8.44B-8.7B-8.7B895.1M847.7M-9.81B-11.09B1.39B1.39B
Long-Term Debt952.8M1.53B1.45B981.3M576.6M568.5M1.59B1.6B1.19B1.59B
Short-Term Debt0000397.3M397.9M1.59B58.8M399.5M0
Total Current Liabilities+452.3M10.15B10.3B10.54B0012.75B399M00
Accounts Payable000000292.5M000
Deferred Revenue000000-467.6M-680.4M00
Other Current Liabilities-452.3M-485.4M-554.2M-525.4M-948.2M-1.07B10.76B-9M-932.4M-547.5M
Deferred Taxes01000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Liabilities12.28B12.56B13.22B13.2B-688.8M-705.8M-1.84B17.35B-1.3B-1.72B
Total Equity+3.88B4.47B4.73B5.15B6B6.19B6.89B6.17B6.41B5.62B
Equity Growth %-0.01%0.15%0.06%0.09%0.17%0.03%0.11%-0.11%0.04%-0.12%
Shareholders Equity3.88B4.47B4.73B5.15B6B6.19B6.89B6.17B6.41B5.62B
Minority Interest0000000000
Retained Earnings2.94B3.21B3.21B3.85B4.39B4.39B5.21B5.32B5.64B5.52B
Common Stock261.9M262.7M269.2M302.7M303.6M304.1M307.5M296.9M278.3M248.8M
Accumulated OCI29.2M323.6M474.2M-210M77.7M284M78M-522.7M-132.4M-102.4M
Return on Equity (ROE)0.11%0.11%0.12%0.08%0.19%0.09%0.23%0.11%0.1%0.14%
Return on Assets (ROA)0.02%0.03%0.03%0.02%0.05%0.03%0.06%0.03%0.02%0.03%
Equity / Assets----------
Debt / Equity0.25x0.34x0.31x0.19x0.16x0.16x0.23x0.26x0.25x0.28x
Book Value per Share13.1115.0915.8117.1019.9220.7022.7020.3322.4621.35
Tangible BV per Share----------

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+688.2M637.3M452.8M760.5M936.2M1.19B1.31B1.17B880.4M1.23B
Operating CF Growth %4.8%-0.07%-0.29%0.68%0.23%0.27%0.11%-0.11%-0.25%0.4%
Operating CF / Revenue %----------
Net Income422.1M466.9M560.5M370.5M1.06B558.6M1.53B686.4M598.6M852.7M
Depreciation & Amortization26.6M027.2M27.6M26.8M26.9M27.2M28.3M33M0
Stock-Based Compensation2.3M3.1M3.5M3.8M3.7M2.1M3.2M9M19.5M0
Deferred Taxes13.4M40.6M49.5M-69.5M37.2M-18.3M151.4M-37.3M00
Other Non-Cash Items-128.7M-131.6M-315.1M185.9M-712.5M128.9M-962M169.3M421.7M-228.9M
Working Capital Changes381.4M261.4M127.2M172.7M524.6M486.8M557.6M314.9M-192.4M609.6M
Cash from Investing+-449.8M-1.04B-293.9M-239.5M-424.6M-845.2M-936.5M-415M25.3M-7.2M
Capital Expenditures0000000000
Acquisitions000-13.1M-1.2M0000136.6M
Purchase of Investments-1.92B-2.74B-2.45B-2.17B-2.65B-2.65B-3.36B-5.42B-3.48B-4.53B
Sale/Maturity of Investments1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Investing-12.5M9.2M-24.3M-31.9M-28M-41.8M-47.1M-12.3M200K-4.5M
Cash from Financing+-215.2M385M-178.5M-546.5M-533.1M-300M-335.7M-832.7M-783.2M-1.23B
Dividends Paid-191.3M-193.8M-198.8M-498.8M-538.7M-250.1M-1.02B-579.7M-275.5M-271.9M
Share Repurchases-34M000000-281.2M-535.3M-942.2M
Stock Issued12M8.4M17.8M13.1M13.8M6.7M60M26.6M31.1M2M
Debt Issuance (Net)-1000K1000K-1000K-1000K-1000K-1000K1000K0-1000K-1000K
Other Financing1.4M-2.9M6.4M-6.1M200K2M2.7M1.6M1.8M-10.7M
Net Change in Cash+23.1M-14.1M-19.8M-25.6M-21.5M39.9M39.4M-77.1M121.8M-900K
Exchange Rate Effect-100K0-200K-100K0100K-100K0-700K-200K
Cash at Beginning136.7M159.8M145.7M125.9M100.3M78.8M118.7M158.1M81M202.8M
Cash at End159.8M145.7M125.9M100.3M78.8M118.7M158.1M81M202.8M201.9M
Free Cash Flow+688.2M637.3M452.8M760.5M936.2M1.19B1.31B1.17B880.4M1.23B
FCF Growth %4.8%-0.07%-0.29%0.68%0.23%0.27%0.11%-0.11%-0.25%0.4%
FCF Margin %----------
FCF per Share2.322.151.512.533.113.964.323.863.084.69

Key Ratios

Metric2015201620172018201920202021202220232024
Combined Ratio89.05%88.38%88.42%93%82.28%90.4%79.43%89.4%89.7%87.01%
Medical Cost Ratio88.01%87.22%87.1%88.22%78.06%34.51%25.67%30.03%35.55%36.74%
Return on Equity (ROE)10.82%11.18%12.18%7.5%18.96%9.17%23.46%10.51%9.52%14.18%
Return on Assets (ROA)2.48%2.62%2.95%1.91%5.23%2.55%6.42%2.74%2.32%3.14%
Equity / Assets22.68%24.05%24.39%26.63%28.47%27.12%27.59%24.51%24.19%20.18%
Book Value / Share13.1115.0915.8117.119.9220.722.720.3322.4621.35
Debt / Equity0.25x0.34x0.31x0.19x0.16x0.16x0.23x0.26x0.25x0.28x
Revenue Growth4.26%2.33%6.15%-0.07%19.2%-3.95%30.36%-13.47%-10.21%13.41%

Revenue by Segment

2015201620172018201920202021202220232024
General Insurance--------4.12B4.68B
General Insurance Growth---------13.54%
Title Insurance Group------4.45B3.88B2.3B2.33B
Title Insurance Group Growth--------12.73%-40.74%1.46%
Corporate & Other--------9.1M14.6M
Corporate & Other Growth---------60.44%
RFIG Run-off Business---96.1M76.8M60.4M44.1M30M16.4M-
RFIG Run-off Business Growth-----20.08%-21.35%-26.99%-31.97%-45.33%-
Reinsurance Recoverable----------
Reinsurance Recoverable Growth----------
Total of major segments5.64B5.79B6B6.21B6.53B7.27B8.54B8.23B--
Total of major segments Growth-2.72%3.61%3.49%5.12%11.30%17.47%-3.60%--
General Insurance Group3.31B3.35B3.53B3.74B3.92B3.88B4.04B4.32B--
General Insurance Group Growth-1.25%5.27%5.88%4.85%-1.12%4.27%6.76%--
Others118.1M130.4M170.3M169.1M170M149.6M166.6M195.5M--
Others Growth-10.41%30.60%-0.70%0.53%-12.00%11.36%17.35%--
Title Insurance Product Line---2.38B2.53B3.33B----
Title Insurance Product Line Growth----6.56%31.53%----
Intersegment Eliminations-82.3M-94.9M-120.1M-122.7M-121.4M-108.2M----
Intersegment Eliminations Growth--15.31%-26.55%-2.16%1.06%10.87%----

Frequently Asked Questions

Valuation & Price

Old Republic International Corporation (ORI) has a price-to-earnings (P/E) ratio of 13.4x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Old Republic International Corporation (ORI) grew revenue by 13.4% over the past year. This is steady growth.

Yes, Old Republic International Corporation (ORI) is profitable, generating $834.0M in net income for fiscal year 2024 (10.4% net margin).

Dividend & Returns

Yes, Old Republic International Corporation (ORI) pays a dividend with a yield of 2.38%. This makes it attractive for income-focused investors.

Old Republic International Corporation (ORI) has a return on equity (ROE) of 14.2%. This is reasonable for most industries.

Industry Metrics

Old Republic International Corporation (ORI) has a combined ratio of 87.0%. A ratio below 100% indicates underwriting profitability.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.